This clinical trial aims to evaluate the effectiveness of a new treatment for managing chronic pain. Participants will be randomly assigned to receive either the new treatment or a placebo. The trial will monitor changes in pain levels and overall health over a 12-week period.
- Who Can Participate: Adults aged 18-65 with a diagnosis of chronic pain for at least six months
- Study Details: Participants will receive either the new treatment or a placebo and will be required to attend weekly check-ins for the duration of the study
- Study Timelines and Visits: The study will last for 12 weeks, starting from the date of enrollment.Participants will need to attend a total of 12 visits over the course of the study